Imagine a future where people with type 1 diabetes (T1D) won’t need to take insulin for months, possibly years, at a time thanks to a small implant! Encapsulated beta cell replacement therapies could be a game changer. They could liberate people with T1D from the burdens of managing their disease all day, every day. These therapies involve wrapping insulin-producing islet cells in a protective barrier before implanting them into the body. The barrier shields the cells from being destroyed by an attack from the immune system, but the cells are still able to sense changes in blood-sugar levels and release insulin and other required hormones whenever they’re needed. Join us in supporting JDRF’s research for Encapsulation and one of the other six JDRF funded therapies by making a 100% tax deductible donation to Fund A Cure here.